Community nurse
Seal R.
PMID: 9450451
Community Nurse. 1996 Oct;2(9):50.
No abstract available.
Cite
Seal R. Getting the most out of medicines. Community Nurse. 1996;2(9):50
Seal, R. (1996). Getting the most out of medicines. Community nurse, 2(9), 50.
Seal, R. "Getting the most out of medicines." Community nurse vol. 2,9 (1996): 50.
Seal R. Getting the most out of medicines. Community Nurse. 1996 Oct;2(9):50. PMID: 9450451.
Copy
Download .nbib
Journal of the American Medical Association
DRAGSTEDT CA.
PMID: 13587249
J Am Med Assoc. 1958 Nov 22;168(12):1652-5. doi: 10.1001/jama.1958.63000120008010.
No abstract available.
Cite
DRAGSTEDT CA. Oral medication with preparations for prolonged action. J Am Med Assoc. 1958;168(12):1652-5doi: 10.1001/jama.1958.63000120008010.
DRAGSTEDT, C. A. (1958). Oral medication with preparations for prolonged action. Journal of the American Medical Association, 168(12), 1652-5. https://doi.org/10.1001/jama.1958.63000120008010
DRAGSTEDT, C A. "Oral medication with preparations for prolonged action." Journal of the American Medical Association vol. 168,12 (1958): 1652-5. doi: https://doi.org/10.1001/jama.1958.63000120008010
DRAGSTEDT CA. Oral medication with preparations for prolonged action. J Am Med Assoc. 1958 Nov 22;168(12):1652-5. doi: 10.1001/jama.1958.63000120008010. PMID: 13587249.
Copy
Download .nbib
Pediatrics
FORBES GB.
PMID: 13613856
Pediatrics. 1959 Jan;23(1):3-5.
No abstract available.
Cite
FORBES GB. Body surface as a basis for dosage. Pediatrics. 1959;23(1):3-5
FORBES, G. B. (1959). Body surface as a basis for dosage. Pediatrics, 23(1), 3-5.
FORBES, G B. "Body surface as a basis for dosage." Pediatrics vol. 23,1 (1959): 3-5.
FORBES GB. Body surface as a basis for dosage. Pediatrics. 1959 Jan;23(1):3-5. PMID: 13613856.
Copy
Download .nbib
Nederlands tijdschrift voor geneeskunde
Vos EJ, Huitema AD.
PMID: 17036864
Ned Tijdschr Geneeskd. 2006 Sep 23;150(38):2104-7.
The revised Dutch Medical Research in Human Subjects Act (WMO), which implements the European directive regarding 'good clinical practice in the conduct of clinical trials on medicinal products for human use' (2001/20/EC), became effective on March 1, 2006. The...
Cite
Vos EJ, Huitema AD. Afbakening van geneesmiddelenonderzoek volgens de gewijzigde wet Medisch-wetenschappelijk Onderzoek met Mensen (WMO). [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)]. Ned Tijdschr Geneeskd. 2006;150(38):2104-7
Vos, E. J., & Huitema, A. D. (2006). Afbakening van geneesmiddelenonderzoek volgens de gewijzigde wet Medisch-wetenschappelijk Onderzoek met Mensen (WMO). [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)]. Nederlands tijdschrift voor geneeskunde, 150(38), 2104-7.
Vos, E J, and Huitema, A D R. "Afbakening van geneesmiddelenonderzoek volgens de gewijzigde wet Medisch-wetenschappelijk Onderzoek met Mensen (WMO)." [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)]. Nederlands tijdschrift voor geneeskunde vol. 150,38 (2006): 2104-7.
Vos EJ, Huitema AD. Afbakening van geneesmiddelenonderzoek volgens de gewijzigde wet Medisch-wetenschappelijk Onderzoek met Mensen (WMO). [Defining trials of medicinal products according to the revised Dutch Medical Research in Human Subjects Act (WMO)]. Ned Tijdschr Geneeskd. 2006 Sep 23;150(38):2104-7. Dutch. PMID: 17036864.
Copy
Download .nbib
International journal of cancer
Liu Y, Miyoshi H, Nakamura M.
PMID: 17390371
Int J Cancer. 2007 Jun 15;120(12):2527-37. doi: 10.1002/ijc.22709.
The diagnosis and treatment of cancer or tumor at the cellular level will be greatly improved with the development of techniques that enable the delivery of analyte probes and therapeutic agents into cells and cellular compartments. Organic and inorganic...
Cite
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007;120(12):2527-37doi: 10.1002/ijc.22709.
Liu, Y., Miyoshi, H., & Nakamura, M. (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. International journal of cancer, 120(12), 2527-37. https://doi.org/10.1002/ijc.22709
Liu, Yiyao, et al. "Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles." International journal of cancer vol. 120,12 (2007): 2527-37. doi: https://doi.org/10.1002/ijc.22709
Liu Y, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer. 2007 Jun 15;120(12):2527-37. doi: 10.1002/ijc.22709. PMID: 17390371.
Copy
Download .nbib
Die Pharmazie
LOEWE FH.
PMID: 18918344
Pharmazie. 1947 Nov;2(11):511.
No abstract available.
Cite
LOEWE FH. Ein vollautomatisches Dosiergerät für chemische und medizinische Laboratorien. A fully automatic dosing device for chemical and medical laboratories. Pharmazie. 1947;2(11):511
LOEWE, F. H. (1947). Ein vollautomatisches Dosiergerät für chemische und medizinische Laboratorien. A fully automatic dosing device for chemical and medical laboratories. Die Pharmazie, 2(11), 511.
LOEWE, F H W. "Ein vollautomatisches Dosiergerät für chemische und medizinische Laboratorien." A fully automatic dosing device for chemical and medical laboratories. Die Pharmazie vol. 2,11 (1947): 511.
LOEWE FH. Ein vollautomatisches Dosiergerät für chemische und medizinische Laboratorien. A fully automatic dosing device for chemical and medical laboratories. Pharmazie. 1947 Nov;2(11):511. German. PMID: 18918344.
Copy
Download .nbib
British journal of nursing (Mark Allen Publishing)
Wright K.
PMID: 19525913
Br J Nurs. 2009 Jun 11-24;18(11):685-9. doi: 10.12968/bjon.2009.18.11.42721.
This second part of a three-part series of articles examining drug calculation skills, focuses on the different methods that can be used to solve drug calculations. It builds on Part 1 (Supporting the development of calculating skills in nurses,...
Cite
Wright K. Developing methods for solving drug dosage calculations. Br J Nurs. 2009;18(11):685-9doi: 10.12968/bjon.2009.18.11.42721.
Wright, K. (2009). Developing methods for solving drug dosage calculations. British journal of nursing (Mark Allen Publishing), 18(11), 685-9. https://doi.org/10.12968/bjon.2009.18.11.42721
Wright, Kerri. "Developing methods for solving drug dosage calculations." British journal of nursing (Mark Allen Publishing) vol. 18,11 (2009): 685-9. doi: https://doi.org/10.12968/bjon.2009.18.11.42721
Wright K. Developing methods for solving drug dosage calculations. Br J Nurs. 2009 Jun 11-24;18(11):685-9. doi: 10.12968/bjon.2009.18.11.42721. PMID: 19525913.
Copy
Download .nbib
Paediatric drugs
Walti H.
PMID: 18590341
Paediatr Drugs. 2008;10(4):207-8. doi: 10.2165/00148581-200810040-00001.
No abstract available.
Cite
Walti H. Medications for premature neonates: healthcare considerations. Paediatr Drugs. 2008;10(4):207-8doi: 10.2165/00148581-200810040-00001.
Walti, H. (2008). Medications for premature neonates: healthcare considerations. Paediatric drugs, 10(4), 207-8. https://doi.org/10.2165/00148581-200810040-00001
Walti, Hervé. "Medications for premature neonates: healthcare considerations." Paediatric drugs vol. 10,4 (2008): 207-8. doi: https://doi.org/10.2165/00148581-200810040-00001
Walti H. Medications for premature neonates: healthcare considerations. Paediatr Drugs. 2008;10(4):207-8. doi: 10.2165/00148581-200810040-00001. PMID: 18590341.
Copy
Download .nbib
IDrugs : the investigational drugs journal
Bawa R.
PMID: 17642014
IDrugs. 2007 Jul;10(7):455-8.
No abstract available.
Cite
Bawa R. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. IDrugs. 2007;10(7):455-8
Bawa, R. (2007). PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. IDrugs : the investigational drugs journal, 10(7), 455-8.
Bawa, Raj. "PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine." IDrugs : the investigational drugs journal vol. 10,7 (2007): 455-8.
Bawa R. PharmaMedDevice 2007. Issues in nanodrug delivery and personalized medicine. IDrugs. 2007 Jul;10(7):455-8. PMID: 17642014.
Copy
Download .nbib
Journal of clinical pharmacology
Dykstra K, Pugh R, Krause A.
PMID: 20881226
J Clin Pharmacol. 2010 Sep;50(9):130S-139S. doi: 10.1177/0091270010376969.
Communication of analysis and simulation results via graphical presentation is a cornerstone of pharmacometric analysis. A modeling and simulation (M&S) project typically has 3 distinct phases: (1) exploratory data analysis, (2) model building, and (3) simulation. Each phase has...
Cite
Dykstra K, Pugh R, Krause A. Visualization concepts to enhance quantitative decision making in drug development. J Clin Pharmacol. 2010;50(9):130S-139Sdoi: 10.1177/0091270010376969.
Dykstra, K., Pugh, R., & Krause, A. (2010). Visualization concepts to enhance quantitative decision making in drug development. Journal of clinical pharmacology, 50(9), 130S-139S. https://doi.org/10.1177/0091270010376969
Dykstra, Kevin, et al. "Visualization concepts to enhance quantitative decision making in drug development." Journal of clinical pharmacology vol. 50,9 (2010): 130S-139S. doi: https://doi.org/10.1177/0091270010376969
Dykstra K, Pugh R, Krause A. Visualization concepts to enhance quantitative decision making in drug development. J Clin Pharmacol. 2010 Sep;50(9):130S-139S. doi: 10.1177/0091270010376969. PMID: 20881226.
Copy
Download .nbib
Journal of clinical pharmacology
Gobburu JV.
PMID: 20881229
J Clin Pharmacol. 2010 Sep;50(9):151S-157S. doi: 10.1177/0091270010376977.
This special issue of the Journal of Clinical Pharmacology is dedicated to pharmacometrics, covering topics related to methodological research, application to decisions, standardization, PhRMA survey, and growth strategy. Innovative methodological and technological advances in analyzing disease, drug, and trial...
Cite
Gobburu JV. Pharmacometrics 2020. J Clin Pharmacol. 2010;50(9):151S-157Sdoi: 10.1177/0091270010376977.
Gobburu, J. V. (2010). Pharmacometrics 2020. Journal of clinical pharmacology, 50(9), 151S-157S. https://doi.org/10.1177/0091270010376977
Gobburu, Jogarao V S. "Pharmacometrics 2020." Journal of clinical pharmacology vol. 50,9 (2010): 151S-157S. doi: https://doi.org/10.1177/0091270010376977
Gobburu JV. Pharmacometrics 2020. J Clin Pharmacol. 2010 Sep;50(9):151S-157S. doi: 10.1177/0091270010376977. PMID: 20881229.
Copy
Download .nbib
Revista medica cubana
CLERCH RIUS A, GOMEZ M.
PMID: 18099380
Rev Med Cubana. 1948 Jul;59(7):516-20.
No abstract available.
Cite
CLERCH RIUS A, GOMEZ M. Determinación de diversos medicamentos contenidos en tabletas, e inyectables. Determination of various drugs contained in tablets and injectables. Rev Med Cubana. 1948;59(7):516-20
CLERCH RIUS, A., & GOMEZ, M. (1948). Determinación de diversos medicamentos contenidos en tabletas, e inyectables. Determination of various drugs contained in tablets and injectables. Revista medica cubana, 59(7), 516-20.
CLERCH RIUS, A, and GOMEZ, M. "Determinación de diversos medicamentos contenidos en tabletas, e inyectables." Determination of various drugs contained in tablets and injectables. Revista medica cubana vol. 59,7 (1948): 516-20.
CLERCH RIUS A, GOMEZ M. Determinación de diversos medicamentos contenidos en tabletas, e inyectables. Determination of various drugs contained in tablets and injectables. Rev Med Cubana. 1948 Jul;59(7):516-20. Spanish. PMID: 18099380.
Copy
Download .nbib
